Skip to content

Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis

Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06884839
Enrollment
30
Registered
2025-03-19
Start date
2022-04-01
Completion date
2025-04-01
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Metastasis, Prognosis, Survival, Tumor Deposits

Brief summary

This study aims to evaluate the tumor deposits in colorectal cancer and its prognostic value in survival and metastasis

Detailed description

Tumor deposits (TDs) are defined as isolated tumor foci found in the pericolonic or perirectal fat or the adjacent mesentery (mesocolonic fat) away from the invasive margin of the tumor without evidence of residual lymphatic tissue. TDs are significantly correlated with poor prognosis after colorectal cancer surgery.

Interventions

PROCEDURETherapeutic resection

Patients with colorectal cancer underwent therapeutic resection with pathologically positive tumor deposits (TDs) to determine distant metastasis occurrence and the effect of TDs on survival.

Sponsors

Minia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age above 18 years old. * Both sexes. * All Colorectal cancer patients From Stage I to III Colorectal cancer with pathologically positive Tumor deposits.

Exclusion criteria

* Patient took neoadjuvant therapy. * No information available on tumor deposits. * Colorectal cancer is not the only primary cancer. * Patients with incomplete information about follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Patients' overall survival2 years postoperativelyPatients' overall survival (OS) is defined as from colorectal cancer (CRC) diagnosis to death.

Secondary

MeasureTime frameDescription
Distant metastasis2 years postoperativelyDistant metastasis is defined as the presence of liver, lung, bone, or brain metastases during or after colorectal cancer (CRC) diagnosis.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026